HomeResearchDMEA 2026
Digital Health · Conference · Berlin 2026

DMEA 2026: Where Digital Health Is Heading in the EU

CEBM 5 · notes ★★☆☆☆ 2 / 5 Personal observations from the trade fair, not a study. These are trends and impressions, not proven effects.

DMEA is Europe's largest digital medicine trade fair. Here is what stood out at the 2026 edition in Berlin: the market is clearly maturing.

What is reaching saturation

AI scribing (voice-driven auto-filling of medical records) in healthcare information systems is reaching saturation. It is now a basic requirement, not a killer feature.

What is growing

Clinical LLMs with a built-in evidence base are gaining ground. Longevity tracking with microbiome analytics is starting to appear.

50+
digital therapeutic products (DiGA) are already reimbursed by Germany's statutory health insurance. This is a working monetization model for digital health.
Why it matters

Europe is consolidating around evidence-based clinical AI and clear reimbursement models. The hype is giving way to a simple question: "Where is the evidence, and who pays?"

The takeaway

The market has grown up. The winners are not the loudest demos but the solutions backed by clinical evidence with payment built in.

Review: notes from DMEA 2026, Berlin, "Double Blind"
Read on Telegram ↗
← All "Decoding the Evidence" reviews